Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 828

1.

Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3.

Li S, Jiang K, Li J, Hao X, Chu W, Luo C, Zhu Y, Xie R, Chen B.

J Ovarian Res. 2020 Feb 22;13(1):20. doi: 10.1186/s13048-020-00621-y.

2.

Characteristics and treatment results of recurrence in adult-type granulosa cell tumor of ovary.

Zhao D, Zhang Y, Ou Z, Zhang R, Zheng S, Li B.

J Ovarian Res. 2020 Feb 14;13(1):19. doi: 10.1186/s13048-020-00619-6.

3.

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols.

Mathieu d'Argent E, Ferrier C, Zacharopoulou C, Ahdad-Yata N, Boudy AS, Cantalloube A, Levy R, Antoine JM, Daraï E, Bendifallah S.

J Ovarian Res. 2020 Feb 13;13(1):18. doi: 10.1186/s13048-020-00620-z.

4.
5.

Integrative analysis of transcription factors and microRNAs in ovarian cancer cell spheroids.

Park H, Hwang S, Jeong JY, Jung SG, Choi MC, Joo WD, Song SH, Lee C, An HJ.

J Ovarian Res. 2020 Feb 11;13(1):16. doi: 10.1186/s13048-020-00618-7.

6.

Elucidating Decorin's role in the preovulatory follicle.

Kedem A, Ulanenko-Shenkar K, Yung Y, Yerushalmi GM, Maman E, Hourvitz A.

J Ovarian Res. 2020 Feb 10;13(1):15. doi: 10.1186/s13048-020-0612-3.

7.

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.

Nagao S, Kogiku A, Suzuki K, Shibutani T, Yamamoto K, Jimi T, Kitai M, Shiozaki T, Matsuoka K, Yamaguchi S.

J Ovarian Res. 2020 Feb 7;13(1):14. doi: 10.1186/s13048-020-0617-y.

8.

MiR-140 targets RAP2A to enable the proliferation of insulin-treated ovarian granulosa cells.

Xiong Z, Li B, Wang W, Zeng X, Li B, Jian S, Wang L.

J Ovarian Res. 2020 Feb 5;13(1):13. doi: 10.1186/s13048-020-0611-4.

9.

Decreased ovarian function and autophagy gene methylation in aging rats.

Li Q, Cai M, Wang J, Gao Q, Guo X, Jia X, Xu S, Zhu H.

J Ovarian Res. 2020 Feb 3;13(1):12. doi: 10.1186/s13048-020-0615-0.

10.

Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.

Pourteymour Fard Tabrizi F, Hajizadeh-Sharafabad F, Vaezi M, Jafari-Vayghan H, Alizadeh M, Maleki V.

J Ovarian Res. 2020 Jan 31;13(1):11. doi: 10.1186/s13048-020-0616-z. Review.

11.

Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.

Yang D, He Y, Wu B, Deng Y, Wang N, Li M, Liu Y.

J Ovarian Res. 2020 Jan 27;13(1):10. doi: 10.1186/s13048-020-0613-2.

12.

Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells.

Cheng L, Zhang K, Qing Y, Li D, Cui M, Jin P, Xu T.

J Ovarian Res. 2020 Jan 22;13(1):9. doi: 10.1186/s13048-020-0609-y.

13.

The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ.

Wang Q, Zhao L, Han L, Fu G, Tuo X, Ma S, Li Q, Wang Y, Liang D, Tang M, Sun C, Wang Q, Song Q, Li Q.

J Ovarian Res. 2020 Jan 18;13(1):8. doi: 10.1186/s13048-019-0603-4.

14.

Relationship between the timing of the first postpartum ovulation and antral follicle counts in Holstein cows.

Furukawa E, Masaki T, Sakaguchi K, Bo M, Yanagawa Y, Ueda K, Nagano M.

J Ovarian Res. 2020 Jan 11;13(1):7. doi: 10.1186/s13048-020-0610-5.

15.
16.

Neuropeptide Y regulates proliferation and apoptosis in granulosa cells in a follicular stage-dependent manner.

Urata Y, Salehi R, Lima PDA, Osuga Y, Tsang BK.

J Ovarian Res. 2020 Jan 8;13(1):5. doi: 10.1186/s13048-019-0608-z.

17.

LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer.

Zhu D, Huang X, Liang F, Zhao L.

J Ovarian Res. 2020 Jan 6;13(1):3. doi: 10.1186/s13048-019-0599-9.

18.

Lipid droplets in granulosa cells are correlated with reduced pregnancy rates.

Raviv S, Hantisteanu S, Sharon SM, Atzmon Y, Michaeli M, Shalom-Paz E.

J Ovarian Res. 2020 Jan 6;13(1):4. doi: 10.1186/s13048-019-0606-1.

19.

Female reproductive potential after oncological treatment: a rare case report of acute myeloid leukemia in monozygotic twin sisters with literature review.

Burnik Papler T, Vrtacnik Bokal E, Jančar N.

J Ovarian Res. 2020 Jan 3;13(1):2. doi: 10.1186/s13048-019-0607-0.

20.

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer.

Jeong SY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS, Lee YY.

J Ovarian Res. 2019 Dec 31;13(1):1. doi: 10.1186/s13048-019-0602-5.

Supplemental Content

Loading ...
Support Center